Logan Lutton

Cassie Houff, MBA, says the most impactful change for U.S. healthcare would be “an overhaul to the fee-for-service payment system,” arguing that it doesn’t incentivize timely or necessary care.

The United States has the highest maternal mortality rate of any high-income country, a crisis perpetuated by the lack of federal funding of pregnancy research, according to a review published in JAMA Health Forum.

The Teal Wand was recently approved by the FDA as the first self-collection device to screen for cervical cancer, a major step forward for accessible women’s health, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.

Although 52% of healthcare leaders believe a fatal cyber-related patient incident will happen within the next five years, cybersecurity was not ranked as a top business challenge, according to the results of Omega Systems’ 2025 Healthcare IT Landscape Report.

How pharmaceutical tariffs could reshape drug pricing, supply chains and domestic production in the United States, according to Eric Tichy, Pharm.D., M.B.A., vice chair of pharmacy formulary at the Mayo Clinic Health System.

Lack of insurance, financial instability and even fear are potential reasons women may forego their cervical cancer screening appointments, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.

Satellos Bioscience Chief Scientific Officer discusses early-stage trials of the company's Duchenne muscular dystrophy drug, SAT-3247.

Satellos Bioscience's experimental small-molecule drug for Duchenne muscular dystrophy is showing positive results as a stand-alone treatment, but Phil Lambert, Ph.D., the company's chief scientific officer says the complexity of Duchenne muscular dystrophy may ultimately mean that a number of different therapies will be used together,

Phil Lambert, Ph.D., chief scientific officer of Satellos Bioscience Inc., explains the mechanism of action of the company's experimental Duchenne muscular dystrophy drug, SAT-3247, and the thinking behind it.

Nancy Hoyt Taff, M.P.H., is the senior product manager of Medicaid at UCare, an independent, nonprofit health plan providing healthcare and administrative services to more than 600,000 members throughout Minnesota and parts of western Wisconsin.

Amanda M. Shafton, CNM, DNP, FACNM, advocates for more midwives in the U.S. healthcare system, arguing that many other countries already see their value.

Ben Scharfe, CPA, shares how his career-changing advice came from an unlikely person.

Patrick Roberts, Pharm.D., said his career changed when he listened to a mentor encouraging him to go back to school.

Kate Masino, MBA, says her career path was changed while watching her chronically ill, aging parents try to navigate the U.S. healthcare system.

Justin Jasniewski, MBA, shared a story about his career turning point and how it involved a rejected proposal and a Big Three PBM seven-figure check.

Approximately 57% of Americans are lonely, with younger generations, Gen Z and Millennials, reporting higher levels than older Americans, a recent Cigna survey shows.

Here’s what you missed this week on Managed Healthcare Executive.

This number can be attributed to claim denials, high deductibles and the underutilization of digital tools available within plans, according to the 2025 U.S. Commercial Member Health Plan Study from J.D. Power.

A growing trend towards pharmaceutical outpatient treatment spending is driven by accessibility, according to Eric Tichy, Pharm.D., M.B.A., vice chair of pharmacy formulary at the Mayo Clinic Health System.

Almost half (48%) of HIV patients sometimes feel unheard by their healthcare providers, which highlights a need for increased disease awareness, according to the early results of a new ViiV Healthcare survey.

GLP-1s are the main reason why pharmacy expenditures have reached double digits in 2025, a continuing trend from 2024, according to Eric Tichy, Pharm.D., M.B.A., vice chair of pharmacy formulary at the Mayo Clinic Health System.

Eric Tichy, Pharm.D., M.B.A., vice chair of pharmacy formulary at the Mayo Clinic Health System, explains potential pharmaceutical spending trends to inform the budgets of health system leaders.

Here’s what you missed this week on Managed Healthcare Executive.

Zynyz is now FDA-approved as the first and only approved first line treatment for advanced squamous cell carcinoma of the anal canal.

Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare barriers, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.

There are several ways to address HIV in homeless populations, with the most promising being the low barrier care model, according to Julie Dombrowski, M.D., M.P.H., professor of medicine at the University of Washington and director of HIV treatment initiatives at the King County, Seattle public health department.

In a Q&A with Leanne Berge, J.D., CEO of Community Health Plan of Washington, Berge explains what the newly proposed Medicaid bill would mean for enrollees and healthcare systems if passed.

Homelessness and HIV share common risk factors, according to Julie Dombrowski, M.D., M.P.H., professor of medicine at the University of Washington and director of HIV treatment initiatives at the King County, Seattle public health department.

Here’s what you missed this week on Managed Healthcare Executive.

While providers do bring up menopause with patients during visits, there are still some knowledge gaps, according to the results of a recent survey of women ages 40 to 70 and healthcare providers.